Acquiring a Regulated Business: When a Change in Ownership Requires Prior Approval

Acquiring a bank, broker, financial intermediary or other licensed enterprise is not an ordinary share transfer with a regulatory application attached. Control of the entity and permission to undertake its regulated activity are separate legal questions. An acquisition can be commercially agreed yet incapable of completing on the terms the parties expect.

Identify the regulator's concept of control

A transaction may transfer control through shares, voting agreements, board appointment rights or other arrangements that give an investor decisive influence. Regulatory provisions may test beneficial ownership or indirect control rather than only the percentage entered on the share transfer form. The buyer must examine the governing statute, licence conditions and regulator-specific approval thresholds before drafting completion mechanics. Instruments such as convertible securities or staged investments should be analysed for the rights they confer before conversion as well as afterwards.

Examine the buyer, not merely the target

The licensed company may have an excellent compliance record and still be unable to complete a proposed acquisition because the incoming persons do not satisfy eligibility requirements. Fitness and propriety, source of funds, group structure, conflicts, management experience and financial resources can be material to the regulator's assessment. A buyer relying on borrowed funds or an undisclosed nominee arrangement should not assume that the concern can be resolved through a boilerplate declaration. Documentation must show who will ultimately own and direct the regulated business.

Draft a workable approval condition

A generic condition that 'all required approvals will be obtained' leaves the parties exposed. The agreement should specify who prepares the filing, who bears costs, what information each must supply, which undertakings may be given and whether the buyer is obliged to accept materially adverse conditions. It should deal with the long-stop date, interim management restrictions and termination if approval is refused or delayed. The seller must continue complying with the licence while the buyer has yet to assume lawful control. An interim covenant that allows the buyer to direct day-to-day regulated activity prematurely can itself be problematic.

Protect value while consent is pending

Customer relationships, regulatory capital, staff eligibility and operating systems can deteriorate during an extended approval process. The acquisition documents should contain proportionate ordinary-course covenants, notification obligations and restrictions on unusual transactions. Those controls must not amount to an unlawful transfer of control before permission is granted. The parties should also consider how breaches discovered by the regulator affect warranties, price and closing rights. If consent is conditional on a change of chief executive or compliance structure, the financial and operational implications must be understood before acceptance.

Approval belongs in the timetable

Regulatory due diligence belongs at the beginning of the acquisition timetable. The parties should distinguish approvals that are legally indispensable from notifications and post-completion filings, document the control structure accurately and allocate the risk of an adverse regulatory decision. An acquisition is not complete merely because the shares can be transferred.